Key result
Rotavirus vaccination linked to a ~21% decrease in cases and net cost savings.
Why the study?
The budget impact and health effects of introducing rotavirus vaccination in Saxony, Germany, from a health insurance perspective with emphasis on herd effect were not assessed.
Does rotavirus vaccination reduce healthcare costs and RV cases in children under 5 years of age?
Observational (n=360,000)
Does rotavirus vaccination reduce healthcare costs and RV cases in children under 5 years of age?
Rotavirus vaccination in Germany was found to be budget neutral or cost-saving for health insurance funds, largely driven by herd protection.
May support budget-neutral RV vaccination policies in Saxony; leaves open generalizability without prospective data.
The objective of this study was to assess the budget impact and health effects of introducing rotavirus (RV) vaccination in Saxony, Germany, from a health insurance perspective. Special emphasis is given to the herd effect. We analyzed direct medical and non-medical costs of RV infection for Social Health Insurance between 2007 and 2010 based on 360,000 routine data observations from the AOK PLUS for children below 5 years of age. We compared the actual annual number of RV cases (vaccination scenario) with the number derived from 2005 (no vaccination, base case scenario). The vaccination coverage rate has increased from 5% to 61% between 2007 and 2010. The number of RV cases decreased by 21% from 32,274 in 2007 to 25,614 in 2010. Based on vaccination coverage, the total cost savings per 1,000 children due to RV vaccination was estimated to be 39,686 Euros. The overall share of outpatient costs was 60%. Mean gross cost savings were expected to be 304 Euros per avoided case. The net cost savings were expected to be 19 Euros per avoided case. About 59% of total savings was due to herd protection resulting from increasing vaccine rates. The herd effect per avoided case increased with increasing vaccine coverage. Incidence of RV cases, vaccination costs and days absent from work were sensitive parameters. This retrospective analysis showed that the increase in RV vaccination coverage in Saxony has been budget neutral if not cost saving for sick funds.
No takes yet. Share an insight, caveat, or question.
Karmann et al. (2014) conducted an observational in Rotavirus gastroenteritis (n=360,000). Rotavirus vaccination vs. No vaccination (base case scenario derived from 2005) was evaluated on Number of rotavirus cases (21% decrease). Rotavirus vaccination in Saxony led to a 21% decrease in rotavirus cases from 2007 to 2010, resulting in expected net cost savings of 19 Euros per avoided case from a health insurance perspective.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: